Atlas FDA

ORTHOSET BONE CEMENT

FDA premarket approval N18466/S023 · decided 1998-10-21

Approval details

PMA number
N18466
Supplement
S023
Supplement type
Real-Time Process
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
ORTHOSET BONE CEMENT
Generic name
BONE CEMENT
Applicant
Depuy, Inc.
Date received
1998-10-01
Decision date
1998-10-21
Days to decision
20 days
Decision code
APPR
Product code
LOD
Advisory committee
Orthopedic
Expedited review
No
Location
Warsaw, IN
Statement
Approval to remove the ascorbic acid and ethanol components from the liquid monomer formulation in your Orthoset 1, Orthoset 2, and Orthoset 3 bone cements, as well as approval to omit the quality control test for dimensional change from the finished product specification.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
PINNACLE CONSTRAINED ACETABULAR LINERS (K043058)Depuy, Inc.2005-03-14
LPS UPPER EXTREMITY (K042664)Depuy, Inc.2004-12-08
LPS (LIMB PRESERVATION SYSTEM) LOWER EXTREMITY DOVETAIL INTERCALARY (K041085)Depuy, Inc.2004-07-22
LPS (K033959)Depuy, Inc.2004-07-01
DURALOC OPTION ACETABULAR CUP SYSTEM, MODELS 1599-01-044 TO -066, 1599-11-044 TO -062 AND 1599-21-044 TO -062 (K040544)Depuy, Inc.2004-05-28
DELTA SHOULDER (K021478)Depuy, Inc.2003-11-18
DEPUY ACE UNIVERSAL AND TROCH ENTRY FEMORAL NAIL SYSTEMS (K033329)Depuy, Inc.2003-11-14
DEPUY SIGMA TIBIAL INSERTS AND CO-CR TIBIAL TRAYS (K032151)Depuy, Inc.2003-09-26